Northeast Pharmaceutical Group Co Ltd
SZSE:000597
Northeast Pharmaceutical Group Co Ltd
Interest Income Expense
Northeast Pharmaceutical Group Co Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Northeast Pharmaceutical Group Co Ltd
SZSE:000597
|
Interest Income Expense
¥84.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Interest Income Expense
¥1.1B
|
CAGR 3-Years
52%
|
CAGR 5-Years
82%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Interest Income Expense
¥134.5m
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
23%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Interest Income Expense
¥429.9m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
30%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Interest Income Expense
¥1.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
37%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Interest Income Expense
¥115.4m
|
CAGR 3-Years
102%
|
CAGR 5-Years
98%
|
CAGR 10-Years
N/A
|
See Also
What is Northeast Pharmaceutical Group Co Ltd's Interest Income Expense?
Interest Income Expense
84.8m
CNY
Based on the financial report for Dec 31, 2023, Northeast Pharmaceutical Group Co Ltd's Interest Income Expense amounts to 84.8m CNY.
What is Northeast Pharmaceutical Group Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
179%
Over the last year, the Interest Income Expense growth was 179%.